Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03467191 · ClinicalTrials.gov registry record · Early Phase 1
Behavioral Alcohol Responses (BAR) Study
A Early Phase 1 study of Alcohol Use Disorder and Alcohol Drinking, sponsored by Carnegie Mellon University.
- Active
- Registry status
- Early Phase 1
- Development phase
- 782
- Enrollment target
- 1
- Study location
NCT03467191 is a Early Phase 1 study of Alcohol Use Disorder and Alcohol Drinking that is active but no longer recruiting, run by Carnegie Mellon University. The registered enrollment target is 782 participants, above the 324-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (141% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03467191, a Early Phase 1 study of Alcohol Use Disorder and Alcohol Drinking, is active but no longer recruiting, sponsored by Carnegie Mellon University.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 782 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to identify risk factors that prospectively predict alcohol problems in young adults.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Alcohol
Study Locations (1)
Pennsylvania
- Carnegie Mellon University - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 782 participants |
| Start Date | 2018-02-13 |
| Est. Completion | 2025-10-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03467191
The ClinicalTrials.gov registry entry for NCT03467191 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 782 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 324-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (141% higher). The listed sponsor is Carnegie Mellon University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03467191 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03467191 about?
NCT03467191 is a clinical study titled "Behavioral Alcohol Responses (BAR) Study". This study aims to identify risk factors that prospectively predict alcohol problems in young adults.
What is the current status of trial NCT03467191?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 782 participants. The study started on 2018-02-13. Estimated completion is 2025-10-31.
What conditions does trial NCT03467191 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Alcohol Drinking, Alcoholism, Alcohol Intoxication, Alcohol; Harmful Use.
What interventions are being tested in trial NCT03467191?
The interventions under investigation include: Placebo (OTHER), Alcohol (DRUG).
Who is sponsoring clinical trial NCT03467191?
This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03467191 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impulsivity Domains and Subjective Response
RECRUITING · Early Phase 1
-
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
RECRUITING · Early Phase 1
-
Suvorexant and Alcohol
RECRUITING · Early Phase 1
-
Anxiety During Abstinence in AUD
RECRUITING · Early Phase 1
-
Diclofenac as a KMO Inhibitor
ACTIVE NOT RECRUITING · Early Phase 1
-
Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study
ACTIVE NOT RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.